CompoAtlas

BUTTER COFFEE SHAKE, BUTTER COFFEE

Supplements listed in USDA FoodData Central

The USDA category is used to select this cohort. It does not establish food supplement status in France or product approval.

This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

Published ingredient list

FILTERED WATER, COCONUT CREAM, MILK PROTEIN CONCENTRATE STRUCTURED LIPID (INTERESTERIFIED CANOLA, MEDIUM-CHAIN TRIGLYCERIDES), COLD BREW COFFEE EXTRACT; LESS THAN 1% OF: ALMOND BUTTER, CALCIUM BETA-HYDROXY-BETA-METHYLBUTYRATE, SALT, NATURAL FLAVORS, MONOPOTASSIUM PHOSPHATE, CAFFEINE, SODIUM ASCORBATE (VITAMIN C - FOR FRESHNESS), ORGANIC STEVIA, GUM ACACIA, AND GELLAN GUM.

Published ingredientRecognised asRole
FILTERED WATERNot recognised
COCONUT CREAMNot recognised
MILK PROTEIN CONCENTRATE STRUCTURED LIPID (INTERESTERIFIED CANOLA, MEDIUM-CHAIN TRIGLYCERIDES)Not recognised
COLD BREW COFFEE EXTRACTNot recognised
ALMOND BUTTERNot recognised
CALCIUM BETA-HYDROXY-BETA-METHYLBUTYRATECalcium
SALTNot recognised
NATURAL FLAVORSNot recognisedFlavouring: gives a smell or taste (Regulation (EC) No 1334/2008).
MONOPOTASSIUM PHOSPHATEPotassium
CAFFEINECAFEINE
SODIUM ASCORBATE (VITAMIN C;FOR FRESHNESS)Vitamine C
ORGANIC STEVIANot recognised
GUM ACACIAacacia senegal
AND GELLAN GUMNot recognised

USDA nutrition values

Published nutrientUSDA contentPublished basisPer serving (calculated)
Fatty acids, total saturated3.38 G100 g or 100 ml (basis unestablished)Not calculated
Total lipid (fat)5.23 G100 g or 100 ml (basis unestablished)Not calculated
Calcium, Ca138 MG100 g or 100 ml (basis unestablished)Not calculated
Cholesterol3 MG100 g or 100 ml (basis unestablished)Not calculated
Fiber, total dietary0 G100 g or 100 ml (basis unestablished)Not calculated
Energy62 KCAL100 g or 100 ml (basis unestablished)Not calculated
Total Sugars0.31 G100 g or 100 ml (basis unestablished)Not calculated
Sodium, Na43 MG100 g or 100 ml (basis unestablished)Not calculated
Protein3.08 G100 g or 100 ml (basis unestablished)Not calculated
Fatty acids, total trans0 G100 g or 100 ml (basis unestablished)Not calculated
Carbohydrate, by difference0.92 G100 g or 100 ml (basis unestablished)Not calculated
Potassium, K308 MG100 g or 100 ml (basis unestablished)Not calculated

The CSV dictionary defines a basis of 100 g; the Branded documentation also provides for 100 ml. The per-serving value is calculated only for an explicit serving in grams. For volumes, the basis remains unestablished and no density is assumed. No daily dose is inferred.

Product record

FDC identifier
1690645
Published brand
ZONEPERFECT
Owner (legal entity)
Abbott Laboratories Inc
Published GTIN
638102673008
Published category
Specialty Formula Supplements
Published serving
325 ml 11 OZA
USDA status
No discontinuation date published
USDA modification date
8 June 2020
USDA availability date
19 March 2021
Published market country
United States

Other USDA observations

Records linked to the same GTIN. Dates and compositions specific to each observation remain separate. A matching GTIN does not guarantee an identical formula. Per-serving values are calculated only for servings in grams, from the content per 100 g. The basis for volumes remains unestablished; no density or daily dose is inferred.

BUTTER COFFEE SHAKE, BUTTER COFFEE, FDC 710746

No discontinuation date published. USDA modification : 20 April 2019 ; USDA availability : 6 December 2019

Published serving: 325 ml 11 OZA.

FILTERED WATER, COCONUT CREAM, MILK PROTEIN CONCENTRATE STRUCTURED LIPID (INTERESTERIFIED CANOLA, MEDIUM-CHAIN TRIGLYCERIDES), COLD BREW COFFEE EXTRACT; LESS THAN 1% OF: ALMOND BUTTER, CALCIUM BETA-HYDROXY-BETA-METHYLBUTYRATE, SALT, NATURAL FLAVORS, MONOPOTASSIUM PHOSPHATE, CAFFEINE, SODIUM ASCORBATE (VITAMIN C - FOR FRESHNESS), ORGANIC STEVIA, GUM ACACIA, AND GELLAN GUM.

Published nutrientUSDA contentPublished basisPer serving (calculated)
Potassium, K308 MG100 g or 100 ml (basis unestablished)Not calculated
Energy62 KCAL100 g or 100 ml (basis unestablished)Not calculated
Sodium, Na43 MG100 g or 100 ml (basis unestablished)Not calculated
Carbohydrate, by difference0.92 G100 g or 100 ml (basis unestablished)Not calculated
Calcium, Ca138 MG100 g or 100 ml (basis unestablished)Not calculated
Fatty acids, total trans0 G100 g or 100 ml (basis unestablished)Not calculated
Total Sugars0.31 G100 g or 100 ml (basis unestablished)Not calculated
Cholesterol3 MG100 g or 100 ml (basis unestablished)Not calculated
Fatty acids, total saturated3.38 G100 g or 100 ml (basis unestablished)Not calculated
Fiber, total dietary0 G100 g or 100 ml (basis unestablished)Not calculated
Protein3.08 G100 g or 100 ml (basis unestablished)Not calculated
Total lipid (fat)5.23 G100 g or 100 ml (basis unestablished)Not calculated

FoodData Central, FDC record 710746

Source: U.S. Department of Agriculture, Agricultural Research Service, FoodData Central, Branded Foods. Data published under CC0 1.0 Universal, https://creativecommons.org/publicdomain/zero/1.0/. Source retrieval date: 2026-11-15.

BUTTER COFFEE SHAKE, BUTTER COFFEE, FDC 1398384

No discontinuation date published. USDA modification : 8 June 2020 ; USDA availability : 26 February 2021

Published serving: 325 ml 11 OZA.

FILTERED WATER, COCONUT CREAM, MILK PROTEIN CONCENTRATE STRUCTURED LIPID (INTERESTERIFIED CANOLA, MEDIUM-CHAIN TRIGLYCERIDES), COLD BREW COFFEE EXTRACT; LESS THAN 1% OF: ALMOND BUTTER, CALCIUM BETA-HYDROXY-BETA-METHYLBUTYRATE, SALT, NATURAL FLAVORS, MONOPOTASSIUM PHOSPHATE, CAFFEINE, SODIUM ASCORBATE (VITAMIN C - FOR FRESHNESS), ORGANIC STEVIA, GUM ACACIA, AND GELLAN GUM.

Nutrition values not supplied in this export.

FoodData Central, FDC record 1398384

Source: U.S. Department of Agriculture, Agricultural Research Service, FoodData Central, Branded Foods. Data published under CC0 1.0 Universal, https://creativecommons.org/publicdomain/zero/1.0/. Source retrieval date: 2026-11-15.

Official source

FoodData Central, FDC 1690645

Source: U.S. Department of Agriculture, Agricultural Research Service, FoodData Central, Branded Foods. Data published under CC0 1.0 Universal, https://creativecommons.org/publicdomain/zero/1.0/. Source retrieval date: 2026-11-15.

CC0 1.0 Universal, public domain

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • CAFFEINE
    Read the warning, when it applies and the studies cited

    CAFFEINE

    Route of administration: Oral (Higdon and Frei 2006)

    Cautions and warnings

    Applies to products providing 100 mg to 400 mg caffeine, per day1.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have high blood pressure or glaucoma (Cornelis and El-Sohemy 2007, Chandrasekaran et al. 2005, Noordzij et al. 2005, Avisar et al. 2002, Arya et al. 2000, Jee et al. 1999, Creighton and Stanton 1990).

    Sources cited by Health Canada (7)
    • Arya LA, Myers DL, Jackson ND. Dietary caffeine intake and the risk for detrusor instability: a case-control study. Obstetrics and Gynecology 2000;96(1):85-89. PubMed
    • Avisar R, Avisar E, Weinberger D. Effect of coffee consumption on intraocular pressure. The Annals of Pharmacotherapy 2002;36(6):992-995. PubMed Randomised trial
    • Chandrasekaran S, Rochtchina E, Mitchell P. Effects of caffeine on intraocular pressure: the Blue Mountains Eye Study. Journal of Glaucoma 2005;14(6):504-507. PubMed
    • Cornelis MC, El-Sohemy A. Coffee, caffeine, and coronary heart disease. Current Opinion in Lipidology 2007;18(1):13-19. PubMed Review article
    • Creighton SM, Stanton SL. Caffeine: does it affect your bladder? British Journal of Urology 1990;66(6):613-614. PubMed Clinical trial
    • Jee SH, He J, Whelton PK, Suh II, Klag MJ. The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials. Hypertension 1999;33(2):647-652. PubMed Meta-analysis
    • Noordzij M, Uiterwaal CS, Arends LR, Kok FJ, Grobbee DE, Geleijnse JM. Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. Journal of Hypertension 2005;23(5):921-928. PubMed Meta-analysis

    1Note: This statement is also required at subtherapeutic quantities for products providing 40 mg or more caffeine per day from all sources for Class II and III applications.

    Applies to products providing more than 300 mg caffeine, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant, breastfeeding, or attempting to conceive (Nawrot et al. 2003).

    Sources cited by Health Canada (1)
    • Nawrot P, Jordan S, Eastwood J, Rotstein J, Hugenholtz A, Feeley M. Effects of caffeine on human health. Food Additives and Contaminants 2003;20(1):1-30. PubMed Review article

    Applies to products providing 400 mg or more caffeine, per day.

    When using this product avoid taking other health products, foods or beverages that contain caffeine and/or increase blood pressure (FDA 2023; Bui et al. 2006; Bouchard et al. 2005; Haller et al. 2005; NIH 2004; Berardi et al. 2002; Vahedi et al. 2000; Zimmerman 1992).

    Sources cited by Health Canada (8)
    • Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
    • Bouchard NC, Howland MA, Greller HA, Hoffman RS, Nelson LS. Ischemic stroke associated with use of an ephedra-free dietary supplement containing synephrine. Mayo Clinic Proceeding 2005;80(4):541-545. PubMed Case report
    • Bui LT, Nguyen DT, Ambrose PJ. Blood pressure and heart rate effects following a single dose of bitter orange. The Annals of Pharmacotherapy 2006;40(1):53-57. PubMed Randomised trial
    • FDA 2023: Food and Drug Administration. Title 21 Chapter 1 Part 340. Stimulant drug products for over-the-counter human use. Washington (DC): U.S. Food and Drug Administration, Department of Health and Human Services; 2023. [Accessed 2023 Aug 28]. Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=340&showFR=1
    • Haller CA, Benowitz NL, Jacob P. Hemodynamic effects of ephedra-free weight-loss supplements in humans. The American Journal of Medicine 2005;118(9):998-1003. PubMed Randomised trial
    • NIH 2004: National Institutes of Health. Office of Dietary Supplements. Fact sheets. Ephedra and ephedrine alkaloids for weight loss and athletic performance; 2004. [Accessed 2023 August 28]. Available from: https://ods.od.nih.gov/factsheets/ephedraandephedrine-HealthProfessional/.
    • Vahedi K, Domingo V, Amarenco P, Bousser MG. Ischaemic stroke in a sportsman who consumed MaHuang extract and creatine monohydrate for body building. Journal of Neurology, Neurosurgery and Psychiatry 2000;68(1):112-113. PubMed Case report
    • Zimmerman DR. Zimmerman's Complete Guide to Nonprescription Drugs, 2nd edition. Detroit (MI): Gale Research Inc.; 1992.

    Contraindications

    Applies to products providing more than 400 mg caffeine per day.

    Do not use if you have high blood pressure or glaucoma (Cornelis and El-Sohemy 2007, Chandrasekaran et al. 2005, Noordzij et al. 2005, Avisar et al. 2002, Arya et al. 2000, Jee et al. 1999, Creighton and Stanton 1990).

    Sources cited by Health Canada (7)
    • Arya LA, Myers DL, Jackson ND. Dietary caffeine intake and the risk for detrusor instability: a case-control study. Obstetrics and Gynecology 2000;96(1):85-89. PubMed
    • Avisar R, Avisar E, Weinberger D. Effect of coffee consumption on intraocular pressure. The Annals of Pharmacotherapy 2002;36(6):992-995. PubMed Randomised trial
    • Chandrasekaran S, Rochtchina E, Mitchell P. Effects of caffeine on intraocular pressure: the Blue Mountains Eye Study. Journal of Glaucoma 2005;14(6):504-507. PubMed
    • Cornelis MC, El-Sohemy A. Coffee, caffeine, and coronary heart disease. Current Opinion in Lipidology 2007;18(1):13-19. PubMed Review article
    • Creighton SM, Stanton SL. Caffeine: does it affect your bladder? British Journal of Urology 1990;66(6):613-614. PubMed Clinical trial
    • Jee SH, He J, Whelton PK, Suh II, Klag MJ. The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials. Hypertension 1999;33(2):647-652. PubMed Meta-analysis
    • Noordzij M, Uiterwaal CS, Arends LR, Kok FJ, Grobbee DE, Geleijnse JM. Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. Journal of Hypertension 2005;23(5):921-928. PubMed Meta-analysis

    Known adverse reactions

    Condition of application: All products.

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if hypersensitivity/allergy occurs (Infante et al. 2003; Hinrichs et al. 2002).

    Sources cited by Health Canada (2)
    • Hinrichs R, Hunzelmann N, Ritzkowsky A, Zollner TM, Krieg T, Scharffetter-Kochanek K. Caffeine hypersensitivity. Allergy 2002;57(9):859-860. PubMed Case report
    • Infante S, Baeza ML, Calvo M, De Barrio M, Rubio M, Herrero T. Anaphylaxis due to caffeine. Allergy 2003;58(7):681-682. PubMed Case report

    Applies to products providing 200 mg or more caffeine, per day.

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms such as chest pain and irregular heartbeat occur (Higgins and Babu 2013).

    Sources cited by Health Canada (1)
    • Higgins JP, Babu KM, Caffeine reduces myocardial blood flow during exercise. The American Journal of Medicine 2013;126(8):730-e 1-8.

    Applies to products providing more than 400 mg caffeine, per day.

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if nervousness, anxiety, insomnia, tremor and/or headache occur (IOM 2001, Zhang 2001, Sawynok 1995).

    Sources cited by Health Canada (3)
    • IOM 2001: Institute of Medicine. Committee on Military Nutrition Research, Food and Nutrition Board, Institute of Medicine. Caffeine for the Sustainment of Mental Task Performance: Formulations for Military Operations. Washington (DC): National Academy Press; 2001 [Accessed 2023 Aug 28]. Available from: http://books.nap.edu/openbook.php?isbn=0309082587.
    • Sawynok J. Pharmacological rationale for the clinical use of caffeine. Drugs 1995;49(1):37-50. PubMed Review article
    • Zhang WY. A benefit-risk assessment of caffeine as an analgesic adjuvant. Drug Safety 2001;24(15):1127-1142. PubMed Review article

    Condition of application: All products except those making a diuretic claim1.

    When using this product diuretic effect may occur.

    1Note: This statement is also required at subtherapeutic quantities for products providing 40 mg or more caffeine per day from all sources for Class II and III applications.

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List in the official revision dated (register: USDA FoodData Central Branded, supplement cohort).

Photograph the packaging

Brand : ZONEPERFECT

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “BUTTER COFFEE SHAKE, BUTTER COFFEE”, https://compoatlas.com/en/supplements/united-states-usda/1690645-butter-coffee-shake-butter-coffee, updated 15 November 2026.

List recorded in 2020. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line